CRDF - Cardiff Oncology, Inc.
3.855
-0.025 -0.649%
Share volume: 646,106
Last Updated: 03-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$3.88
-0.02
-0.01%
Summary score
22%
Profitability
0%
Dept financing
5%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-16.7%
Return on sales
-7261.95%
Return on invested capital
0%
Total debt ratio
18.64%
Debt ratio change over timeo
-0.82%
Current Ratio
5.67%
Quick Ratio
0%
Cash Position Ratio
2.12%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-16.7%
Return on sales
-7261.95%
Return on invested capital
0%
Total debt ratio
18.64%
Debt ratio change over timeo
-0.82%
Current Ratio
5.67%
Quick Ratio
0%
Cash Position Ratio
2.12%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.94%
Return on sales
-8381.33%
Return on invested capital
0%
Total debt ratio
14.65%
Debt ratio change over time
0%
Current Ratio
7.08%
Quick Ratio
0%
Cash Position Ratio
3.83%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-116.15%
Return on sales
-6120.84%
Return on invested capital
0%
Total debt ratio
-81.79%
Debt ratio change over time
-0.82%
Current Ratio
3.94%
Quick Ratio
0%
Cash Position Ratio
0.21%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRDF | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 18.63% | 4.21% | 3.82% |
| Return on assets | -16.7% | 3.07% | 3.15% | 2.36% |
| Return on sales | -7261.95% | 30.43% | 28.87% | 24.63% |
| Return on invested capital | 0% | 5.33% | 2.16% | 3.93% |
| Profitability | 0% | 99% | 64% | 63% |
| Total debt ratio | 18.64% | 92.23% | 67.37% | 47.08% |
| Debt ratio change over time | -0.82% | 18.13% | 116.87% | 2.96% |
| Dept financing | 5% | 29% | 43% | 13% |
| Current Ratio | 5.67% | 1.32% | 1.23% | 1.9% |
| Quick Ratio | 0% | 0.95% | 1.08% | 1.22% |
| Cash Position Ratio | 2.12% | 0.47% | 0.47% | 0.44% |
| Liquididy | 50% | 38% | 28% | 44% |
| Short-term ratios | CRDF | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -23.78% | 3.13% |
| Return on assets | -16.7% | 2.13% | 1.4% | 2.16% |
| Return on sales | -7261.95% | 21.39% | 10.21% | 24.36% |
| Return on invested capital | 0% | 0% | -14.26% | 2.94% |
| Profitability | 0% | 47% | 27% | 100% |
| Total debt ratio | 18.64% | 93.35% | 67.38% | 41.59% |
| Debt ratio change over time | -0.82% | 0% | 8.62% | 18.48% |
| Dept financing | 5% | 25% | 30% | 36% |
| Current Ratio | 5.67% | 1.32% | 1.23% | 1.9% |
| Quick Ratio | 0% | 0.95% | 1.08% | 1.22% |
| Cash Position Ratio | 2.12% | 0.47% | 0.47% | 0.44% |
| Liquididy | 50% | 31% | 33% | 39% |